Variation of the genes encoding the human glutamate EAAT2, serotonin and dopamine transporters and susceptibility to idiopathic generalized epilepsy

Epilepsy Research

Volumn 41, Issue 1, 2000, Pages 75-81

  Sander, Thomas ^a   Berlin, Winnie ^a   Ostapowicz, Agata ^b   Samochowiec, Jerzy ^b   Gscheidel, Nicola ^c   Hoehe, Margret R ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Absence epilepsy; Association; Genetics; Idiopathic generalized epilepsy; Neurotransmitter transporter

Indexed keywords

DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; SEROTONIN TRANSPORTER;

3' UNTRANSLATED REGION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EPILEPTOGENESIS; GENE FREQUENCY; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL;

ALLELES; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; EPILEPSY, GENERALIZED; EXCITATORY AMINO ACID TRANSPORTER 2; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, NEUROTRANSMITTER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VARIATION (GENETICS);

EID: 0033869471     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00120-0     Document Type: Article

References (43)

1. Aoki M., Lin C.L., Rothstein J.D., Geller B.A., Hosler B.A., Munsat T.L., Horvitz H.R., Brown R.H.J. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43:1998;645-653.
2. Applegate C.D., Tecott L.H. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp. Neurol. 154:1998;522-530.
3. Beckman M.L., Quick M.W. Neurotransmitter transporters: regulators of function and functional regulation. J. Membr. Biol. 164:1998;1-10.
4. Beck-Mannagetta G., Janz D. Syndrome-related genetics in generalized epilepsy. Epilepsy Res. 4((Suppl.)):1991;105-111.
5. Berkovic S.F., Andermann F., Andermann E., Gloor P. Concepts of absence epilepsies: discrete syndromes or biological continuum? Neurology. 37:1987;993-1000.
6. Berkovic S.F., Howell R.A., Hay D.A., Hopper J.L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 43:1998;435-445.
7. Chapman A.G. Glutamate receptors in epilepsy. Prog. Brain. Res. 116:1998;371-383.
8. Comings D.E. Polygenic inheritance and micro/minisatellites. Mol. Psychiatry. 3:1998;21-31.
9. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 30:1989;389-399.
10. Dailey J.W., Mishra P.K., Ko K.H., Penny J.E., Jobe P.C. Serotonergic abnormalities in the central nervous system of seizure- naive genetically epilepsy-prone rats. Life Sci. 50:1992;319-326.
11. Delbrück S.J., Wendel B., Grunewald I., Sander T., Morris-Rosendahl D., Crocq M.A., Berrettini W.H., Hoehe M.R. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet. Cell Genet. 79:1997;214-220.
12. Duncan J.S. Idiopathic generalized epilepsies with typical absences. J. Neurol. 244:1997;403-411.
13. Greenberg D.A., Durner M., Delgado-Escueta A.V. Evidence for multiple gene loci in the expression of the common generalized epilepsies. Neurology. 42:1992;56-62.
14. Heils A., Mössner R., Lesch K.P. The human serotonin transporter gene polymorphism - basic research and clinical implications. J. Neural. Transm. 104:1997;1005-1014.
15. Hosford D.A. Models of primary generalized epilepsy. Curr. Opin. Neurol. 8:1995;121-125.
16. Jackson M., Steers G., Leigh P.N., Morrison K.E. Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients. J. Neurol. 246:1999;1140-1144.
17. Janz D. The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia. 38:1997;4-11.
18. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman R.M., White F.J., Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2:1999;649-655.
19. Kang A.M., Palmatier M.A., Kidd K.K. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry. 46:1999;151-160.
20. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
21. Lesch K.P., Heils A., Riederer P. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes. J. Mol. Med. 74:1996;365-378.
22. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 20:1998;589-602.
23. McNamara J.O. Excitatory amino acid receptors and epilepsy. Curr. Opin. Neurol. Neurosurg. 6:1993;583-587.
24. McNamara J.O. Emerging insights into the genesis of epilepsy. Nature. 399:1999;A15-A22.
25. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
26. Mirovsky Y., Yu Y.L., Wagner G.C., Sekowski A., Goldberg M., Fisher H. Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists. Alcohol Clin. Exp. Res. 19:1995;160-163.
27. Noebels J.L. Mutational analysis of spike-wave epilepsy phenotypes. Epilepsy Res. 4((Suppl.)):1991;201-212.
28. Noebels J.L. Targeting epilepsy genes. Neuron. 16:1996;241-244.
29. Owen M.J., Holmans P., McGuffin P. Association studies in psychiatric genetics. Mol. Psychiatry. 2:1997;270-273.
30. Perneger T.V. What's wrong with Bonferroni adjustments. Br. Med. J. 316:1998;1236-1238.
31. Puranam R.S., McNamara J.O. Seizure disorders in mutant mice: relevance to human epilepsies. Curr. Opin. Neurobiol. 9:1999;281-287.
32. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
33. Ryan S.G. Ion channels and the genetic contribution to epilepsy. J. Child Neurol. 14:1999;58-66.
34. Sander T., Harms H., Lesch K.P., Dufeu P., Kuhn S., Hoehe M., Rommelspacher H., Schmidt L.G. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin. Exp. Res. 21:1997;1356-1359.
35. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., Rommelspacher H., Schmidt L.G. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry. 41:1997;299-304.
36. Sander T., Peters C., Kammer G., Samochowiec J., Zirra M., Mischke D., Ziegler A., Kaupmann K., Bettler B., Epplen J.T., Riess O. Association analysis of exonic variants of the gene encoding the GABAB receptor and idiopathic generalized epilepsy. Am. J. Med. Genet. 88:1999;305-310.
37. Sander T. The genetics of idiopathic generalized epilepsy: implications for the understanding of its aetiology. Mol. Med. Today. 2:1996;173-180.
38. Sano A., Kondoh K., Kakimoto Y., Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum. Genet. 91:1993;405-406.
39. SAS Institute Inc., 1988. SAS/STAT User's Guide, Release 6.03 Edition. SAS Institute, Cary, NC.
40. Statnick M.A., Dailey J.W., Jobe P.C., Browning R.A. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia. 37:1996;311-321.
41. Szot P., Reigel C.E., White S.S., Veith R.C. Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy- prone rat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin. Brain Res. Mol. Brain Res. 43:1996;233-245.
42. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1997;1699-1702.
43. Terwilliger J.D., Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum. Hered. 42:1992;337-346.